Food Regulation and Safety Under the New Administration – FDA Watch
In this episode, Shelly and Wayne chat with Stuart Pape, Senior Partner and Chair of the FDA Practice at Polsinelli, and Domenic Veneziano, Independent FDA Regulatory and Strategic Consultant and Owner of Veneziano Consulting. You’ll hear their thoughts on the top priorities in food regulation for the next FDA Commissioner and their insights on increased FSVP inspections, key issues surrounding food importation, the Human Foods program, and other top-of-mind issues.
Headlines
Pharma: FDA Issues Final Rule on Non-Prescription Drug Products
Devices: FDA Answers Questions on Clinical Decision Support Software Functions
Food: FDA Finalizes Updates “Healthy” Nutrient Content Claim
Cosmetics: FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc
Resource Links
Food: FDA Updates “Healthy” Claim, Providing a Refreshed Tool for Consumers
About Our Guests
Stuart Pape

Stuart Pape is a Senior Partner and Food and Drug Chair at Polsinelli. He consults clients on regulations imposed by the U.S. Food and Drug Administration (FDA), U.S. Department of Agriculture (USDA), and similar health and safety regulatory bodies worldwide.
Stuart regularly appears before the FDA, USDA, Consumer Product Safety Commission, U.S. Customs and Border Protection, Federal Trade Commission, numerous other federal and state regulatory bodies, and the Congress of the United States. Stuart serves clients across the U.S. and around the world in many capacities. Previously, he served in various positions in the Office of the Chief of Counsel at the FDA, including as Associate Chief Counsel for food. He also served as executive assistant to FDA Commissioner Donald Kennedy.
Domenic Veneziano

Domenic is an independent FDA Regulatory and Strategic Consultant and Owner of Veneziano Consulting. As a 24-year veteran of FDA and USPHS, Domenic served as the Director of Import Operations in the FDA Office of Regulatory Affairs and had prominent roles in the oversight of FDA’s National import operations program.

